Sonoma pharmaceuticals announces partnership with daewoong pharmaceutical for distribution of primocyn skin care in south korea

Boulder, co / accesswire / january 31, 2023 / sonoma pharmaceuticals, inc. (nasdaq:snoa), a global healthcare leader developing and producing patented microcyn® technology based stabilized hypochlorous acid (hocl) products for a wide range of applications, including dermatology, eye, oral and nasal care, and wound care, today announced that it has entered into a distribution agreement with daewoong pharmaceutical co., ltd. for the marketing and distribution of primocyntm skin solution products in south korea.
SNOA Ratings Summary
SNOA Quant Ranking